Healthcare Capital Corporation News - HCCC

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

0001822935 false Healthcare Capital Corp/DE 0001822935 2022-01-19 2022-01-19 0001822935 HCCC:UnitsEachConsistingOfOneShareOfClassCommonS...

Proxy Statement - Merger or Acquisition (definitive) (defm14a)

Table of Contents ________________________________ SCHEDULE 14A (Rule...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Alpha Tau Medical Ltd. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12...

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®) PR Newswire JERUSALEM, Nov. 3...

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective PR...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Alpha Tau Medical Ltd. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filed by Alpha Tau Medical Ltd. Pursuant to Rule 425 under the Securities Act of 1933 and...

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors...

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment of Solid Tumors...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Healthcare Capital Corporation (HCCC)

Empower your portfolio: Real-time discussions and actionable trading ideas.

HCCC News

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Proxy Statement - Merger or Acquisition (definitive) (defm14a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

Amended Statement of Ownership (sc 13g/a)

Quarterly Report (10-q)

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective

Quarterly Report (10-q)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...

HCCC Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Healthcare Capital Corporation (HCCC) News

Healthcare Capital Corporation (HCCC)

Empower your portfolio: Real-time discussions and actionable trading ideas.

HCCC News

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Current Report Filing (8-k)

Proxy Statement - Merger or Acquisition (definitive) (defm14a)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Alpha Tau Announces Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

Amended Statement of Ownership (sc 13g/a)

Quarterly Report (10-q)

Alpha Tau Announces Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

Alpha Tau Announces Completion of Enrollment in First US Clinical Trial of Alpha DaRT™ and Achievement of First Primary Objective

Quarterly Report (10-q)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...

Alpha Tau and Healthcare Capital Corp. to Combine and Create A Publicly Traded Company Focused on Transforming the Treatment ...

HCCC Discussion

Your Recent History